FDG positron emission tomography for evaluating breast cancer

BlueCross BlueShield Association
Record ID 32003000737
Authors' objectives:

This Assessment reviews evidence on the use of FDG PET imaging in breast cancer and focuses on 4 specific clinical settings: (1) initial diagnosis of breast cancer; (2) staging axillary lymph nodes; (3) detection of locoregional recurrence or distant metastasis/recurrence; and (4) evaluating response to treatment.

Authors' methods: Systematic review
Project Status: Completed
Year Published: 2001
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Tomography, Emission-Computed
  • Breast Neoplasms
Organisation Name: BlueCross BlueShield Association
Contact Address: BlueCross BlueShield Association, Technology Evaluation Center, 225 North Michigan Ave, Chicago, Illinois, USA. Tel: 888 832 4321
Contact Name: tec@bcbsa.com
Contact Email: tec@bcbsa.com
Copyright: BlueCross BlueShield Association (BCBS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.